ASN04885796 (compound IV) is an GPR17 activator with an EC50 of 2.27 nM for GPR17 induced GTPγS binding. ASN04885796 has neuroprotective property and can be used for research of neurological diseases.
References:
[1]. Abbracchio, et al. Gpr17-modulating compounds, diagnostic and therapeutic uses thereof. 2014, US20140148472
















